Irlanda - anglès - HPRA (Health Products Regulatory Authority)

virbac s.a. - feline leukemia virus envelope antigen p45 - suspension for injection - . - feline leukaemia virus - cats - immunological - inactivated vaccine

Nova Zelanda - anglès - Ministry for Primary Industries

zoetis new zealand limited - feline leukaemia virus (inactivated) - feline leukaemia virus (inactivated) 0 vaccine - vaccine

Unió Europea - anglès - EMA (European Medicines Agency)

merial - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against chlamydophila felis infection to reduce clinical signs.onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis, calicivirus and chlamydophila felis components.the duration of immunity is 1 year after the last (re-)vaccination.

Unió Europea - anglès - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals for felidae, - cats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs.onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

Unió Europea - anglès - EMA (European Medicines Agency)

virbac s.a. - purified rp-45 felv-envelope antigen - inactivated viral vaccines - cats - active immunisation of cats from eight weeks of age against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.

Regne Unit - anglès - VMD (Veterinary Medicines Directorate)

eli lilly and company limited - feline calicivirus, feline panleukopenia virus, feline viral rhinotracheitis virus - powder and solvent for solution for injection - live viral vaccine - cats

Regne Unit - anglès - VMD (Veterinary Medicines Directorate)

intervet uk ltd - feline calicivirus, feline panleukopenia virus, feline viral rhinotracheitis virus -

Regne Unit - anglès - VMD (Veterinary Medicines Directorate)

pfizer ltd - feline calicivirus, feline panleukopenia virus, feline viral rhinotracheitis virus -

Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium sa-nv - feline leukemia virus gp70 surface antigen - suspension for injection - feline leukemia virus (felv) - feline leukaemia virus - cat

Unió Europea - anglès - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals for felidae, - cats - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs.onsets of immunity have been demonstrated one week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components.the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.